WASHINGTON: China has been involved in biological activities with potential double use applications, which enhance concerns about their compliance with biological weapons and toxins (BWC) conventions and chemical weapons conventions (CWC), Pentagon said in recent reports.
The study conducted at the Military Medical Institution discusses identifying, testing, and characterizing a variety of powerful poison families with the application of multiple use, said the Pentagon report entitled Military and Security Development involving the People’s Republic of China, 2021.
Based on available information, the US cannot state That Beijing has fulfilled its obligations under CWC because of concerns about Chinese research from pharmaceutical-based agents (PBAs) and poisons with potential multiple usage applications, 192 report pages declared.
It is also said that China invests, and develops, the number of nuclear nuclear platforms based on land, sea and construction needed to support the main expansion of its nuclear power.
Beijing also supports this expansion by increasing its capacity to produce and separate plutonium by building rapid farmer reactors and reprocating facilities.
The US Department of Defense Annual Report (DOD) to Congress on military and security developments involving China was released on Wednesday.
China has long viewed the US as a competitor and has characterized its views on strategic competition in terms of competition among strong nations, and opponent’s system clashes, according to reports.